Literature DB >> 10679920

Novel gene fusion of COX6C at 8q22-23 to HMGIC at 12q15 in a uterine leiomyoma.

K Kurose1, N Mine, D Doi, Y Ota, K Yoneyama, H Konishi, T Araki, M Emi.   

Abstract

Cytogenetic analyses have shown that aberrations involving 12q13-15 are frequent chromosomal changes in a variety of human benign mesenchymal tumors, e.g., pleomorphic adenomas of the parotid gland, pulmonary chondroid hamartomas, lipomas, and uterine leiomyomas. Recently, the high-mobility group protein gene HMGIC was identified as the target gene affected by the 12q13-15 aberrations. Using 3' rapid amplification of cDNA ends experiments, we isolated novel ectopic sequences fused to HMGIC in a uterine leiomyoma. Cloning of the fusion cDNA identified the human cytochrome c oxidase subunit VIc (COX6C) gene on 8q22-23 as the fusion partner of HMGIC. Nucleotide sequences of the fusion transcript revealed that the first 3 exons of the HMGIC gene, encoding the 3 DNA binding domains, was fused to the exon 2 of the COX6C gene. The identification of a gene rearrangement suggests a role for HMGIC in tumorigenesis of uterine leiomyoma and suggests a possible involvement of HMGIC in mesenchymal differentiation. Genes Chromosomes Cancer 27:303-307, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679920     DOI: 10.1002/(sici)1098-2264(200003)27:3<303::aid-gcc11>3.0.co;2-3

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

Review 1.  Differential expression and clinical significance of COX6C in human diseases.

Authors:  Bi-Xia Tian; Wei Sun; Shu-Hong Wang; Pei-Jun Liu; Yao-Chun Wang
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 2.  The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.

Authors:  F Liu; K Y Chau; P Arlotta; S J Ono
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma.

Authors:  Eva Röijer; Anders Nordkvist; Anna-Karin Ström; Walter Ryd; Margareta Behrendt; Jörn Bullerdiek; Joachim Mark; Göran Stenman
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 4.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

5.  Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast.

Authors:  Felipe Fidalgo; Tatiane Cristina Rodrigues; Mabel Pinilla; Amanda Gonçalves Silva; Maria do Socorro Maciel; Carla Rosenberg; Victor Piana de Andrade; Dirce Maria Carraro; Ana Cristina Victorino Krepischi
Journal:  Tumour Biol       Date:  2014-11-13

6.  Fusion of a sequence from HEI10 (14q11) to the HMGIC gene at 12q15 in a uterine leiomyoma.

Authors:  N Mine; K Kurose; H Konishi; T Araki; H Nagai; M Emi
Journal:  Jpn J Cancer Res       Date:  2001-02

Review 7.  High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.

Authors:  Uchenna Unachukwu; Kiran Chada; Jeanine D'Armiento
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

8.  HMGA2: A Biomarker in Gynecologic Neoplasia.

Authors:  Jian-Jun Wei
Journal:  J Clin Transl Pathol       Date:  2022-01-27

Review 9.  Novel role of COX6c in the regulation of oxidative phosphorylation and diseases.

Authors:  Changyu Wang; Jianjun Lv; Chengxu Xue; Jiawen Li; Yanqing Liu; Danni Xu; Yuting Jiang; Shuai Jiang; Minghui Zhu; Yang Yang; Shaofei Zhang
Journal:  Cell Death Discov       Date:  2022-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.